Paratek

Discussion in 'Paratek' started by anonymous, May 17, 2019 at 12:18 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    These recruiters are a joke! Maybe the OIG should look into them stating the UTI indication in their job posting on LinkedIn.
    Right Suzi......
     

  2. anonymous

    anonymous Guest

    Hey Suzi, I see you cleaned up the job posting on UTI indication.
     
  3. anonymous

    anonymous Guest

    Saw there are many open positions here.
    Is this an expansion?
    What’s the status of the Amplity contract?
    What’s the culture like?
    How are sales? Is this a good opportunity?
     
  4. anonymous

    anonymous Guest

    Culture is age discrimination at Amp-lity. They suck.
     
  5. anonymous

    anonymous Guest

    All positions east of Omaha NE are open due to departure’s. Ask how many Hospitals have stocked and put the look alike tetracycline on Formulary and unrestricted use.
     
  6. anonymous

    anonymous Guest

    Oh yeah, New York City area is an expansion area but access sucs.
     
  7. anonymous

    anonymous Guest

    departures?? everyone left on their own or were they pushed out?
     
  8. anonymous

    anonymous Guest

    Who in their right mind would come to prtk? It’s dog shit drug. Just go look at akao this is going to end the same way! Co will be gone soon. Abx are not where u want to be anymore. Take if u absolutely NEED a job. Otherwise run!!
     
  9. anonymous

    anonymous Guest

    That’s right. Everyone here knows the ship is sinking, except for the 5 people who have a tremendous amount of off-label business. There is a real sense of panic and desperation. Once the Amplity contract ends, many heads will be cut. The VP of sales and head of training just got fired. They were scapegoats for a poor marketing plan.
    Look at the financials. The sales are never going to be able to support 55 reps. (And wasn’t the second round of hiring supposed to hire 40 reps rather than 15?)
    There are too many other options that work, that don’t come close to costing $3,000 to $6,000, that are covered, and that don’t take a day or two to get through specialty pharmacy.
    Run far away from this shitshow.
     
  10. anonymous

    anonymous Guest

    Run like a big pharma company.
    I had re-certify because I didn’t use Nancy.
     
  11. anonymous

    anonymous Guest

    Nancy?? Being recruited but many red flags....
     
  12. anonymous

    anonymous Guest


    Spoke to several reps that left to sell Nabriva's Lefamulin said management has no idea how to launch an antibiotic. Few territories have any sales but have significant pressure to obtain formulary wins that take time. Clinical data showed no real improvements versus what is currently already in generic form and considerably less expensive. YAWN!
     
  13. anonymous

    anonymous Guest

    have to call BS that you spoke with anyone who left because no one left in general or for Nabriva. So the rest of your comments are not credible. Bye troll
     
  14. anonymous

    anonymous Guest

    "In General" God you are a fucking moron! I am one of those that left! Here to warn anyone that wants to backfill openings, RUN! Total shit show on display front and center.
     
  15. anonymous

    anonymous Guest

    Sorry that the stock price is so looowwww!
     
  16. anonymous

    anonymous Guest

    You said you spoke to several who left for Nabriva. Not one person did that.
    Now you change your narrative that you left. Pretty convenient as you didn’t mention before. You mean you were let go because you didn’t perform well? That I can confirm. People were let go.
    Maybe you should let go and move on
     
  17. anonymous

    anonymous Guest

    Good luck to all!
     
  18. anonymous

    anonymous Guest

    You are delusional, would recommend you take your medications as RX by your doctor.
     
  19. anonymous

    anonymous Guest

     
  20. anonymous

    anonymous Guest


    Nobody is performing well, unless you are one of the few that have off-label business.
    Promised Wall Street 10-13M in sales for 2019. Delivered only 3M through 2Q. Everyone here knows that 3Q is not looking good, thus the sense of panic and desperation. 10-13M this year ain’t happening.
    No hospitals are adding Nuzyra to formulary. Xerava is getting P&T approvals.
    How much longer will the board allow management to lose 30M+ each quarter?